Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis

Ennio Polilli1, Federica Sozio2, Antonella Frattari3

  • 1Clinical Pathology Unit, Pescara General Hospital, Pescara, Italy.

Plos One
|January 11, 2020
PubMed

Insights

Monocyte Distribution Width (MDW) shows promise in identifying sepsis, performing similarly to Procalcitonin (PCT). This new marker, when combined with routine blood counts, could aid in sepsis detection.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Hematology

Background:

  • Early identification of sepsis is crucial for patient outcomes.
  • Procalcitonin (PCT) is a recognized biomarker for bacterial infections and sepsis.
  • Novel biomarkers are needed to complement existing diagnostic tools.

Purpose of the Study:

  • To evaluate Monocyte Distribution Width (MDW) as a potential biomarker for sepsis detection.
  • To compare the diagnostic performance of MDW against Procalcitonin (PCT).
  • To assess the utility of MDW in conjunction with routine blood counts for sepsis identification.

Main Methods:

  • Prospective observational study enrolling patients hospitalized for bacterial infection or sepsis.
  • Collected data included clinical characteristics, demographics, medical history, microbiological results, PCT, and neutrophil/monocyte indices.
  • Multivariate analysis and ROC curve analysis were used to evaluate MDW and PCT performance.

Main Results:

  • Sepsis was diagnosed in 40.4% of 260 enrolled patients.
  • Both MDW (OR: 1.57) and PCT >1 ng/mL (OR: 48.5) were independently associated with sepsis.
  • MDW demonstrated a high diagnostic accuracy (AUC: 0.87), comparable to PCT (AUC: 0.88).

Conclusions:

  • MDW is a promising biomarker for sepsis detection, with performance similar to PCT.
  • Incorporating MDW into routine white blood cell counts may enhance sepsis detection capabilities.
  • Further research is warranted to validate these findings and establish clinical utility.

Related Concept Videos